• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Esophageal candida infection associated with increased esophageal cancer risk in patients with achalasia

bySimon PanandAlex Chan
January 24, 2025
in Chronic Disease, Gastroenterology, Infectious Disease, Oncology, Weekly Rewinds, Wellness
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. Among 234 patients with achalasia, esophageal candidiasis was identified in 12%.

2. Among patients with achalasia, prior esophageal candidiasis, older age at diagnosis and male sex were associated with an increased risk of developing esophageal cancer (EC).

Evidence Rating Level: 2 (Good)

Patients with achalasia are at higher risk of developing EC. However, the specific pathophysiological mechanism underlying this phenomenon has not been well established. A recent hypothesis posits that food stasis promotes the overgrowth of microorganisms like bacteria and some fungal species which can cause chronic inflammation leading to dysplasia of the esophageal mucosa. This retrospective cohort study therefore sought to investigate the prevalence of esophageal Candida infection in patients with achalasia and to evaluate its association with the development of EC. 234 patients (median [IQR] age at diagnosis, 45 [32-63] years; 50% female) with achalasia at the Erasmus University Medical Centre between January 1980 and May 2024 were included in the study. During follow-up, 29 patients (12%) experienced at least 1 episode of esophageal candidiasis while 24 patients (10%) experienced EC. Using Cox proportional hazards regression models with esophageal candidiasis as a time-varying covariate, Candida infection was associated with an increased risk of developing EC (crude univariate HR, 10.44 [95% CI, 3.78-28.83]; P < .001). Overall, this study found that the prevalence of esophageal Candida infection in patients with achalasia was 12%, and that esophageal candidiasis was associated with a higher risk of developing EC.

Click to read the study in JAMA Network Open

Image: PD

RELATED REPORTS

Mobile telemedicine is associated with higher chances of initiating hepatitis C virus treatment in intravenous drug users with chronic hepatitis C

Lyme disease is associated with significant health care costs

Ethosuximide may not be effective for the treatment of abdominal pain in irritable bowel syndrome

©2025 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc. 

Tags: candidachronic diseaseesophageal cancerGastroenterologyinfectious disease
Previous Post

#VisualAbstract: Increased Survival with Trastuzumab Emtansine in Residual HER2-Positive Breast Cancer Relative to Trastuzumab Alone

Next Post

Poor rates of surveillance follow-up noted in patients with high risk human papillomavirus and normal cytology

RelatedReports

Screening insufficient for newborns exposed to hepatitis C virus
Chronic Disease

Mobile telemedicine is associated with higher chances of initiating hepatitis C virus treatment in intravenous drug users with chronic hepatitis C

February 2, 2026
Longer duration of antibiotic therapy does not reduce persistent symptoms in Lyme disease
Infectious Disease

Lyme disease is associated with significant health care costs

January 19, 2026
Unenhanced magnetic resonance imaging highly sensitive and specific for acute appendicitis
Chronic Disease

Ethosuximide may not be effective for the treatment of abdominal pain in irritable bowel syndrome

January 20, 2026
Mild-to-moderate hypertriglyceridemia associated with higher risk of acute pancreatitis
Cardiology

Association between atrial fibrillation and both the in-hospital mortality and disease severity in acute pancreatitis: insights from a multicenter study

January 12, 2026
Next Post
Quick Take: T-Cell Receptor Gene Therapy for Human Papillomavirus–Associated Epithelial Cancers: A First-in-Human, Phase I/II Study

Poor rates of surveillance follow-up noted in patients with high risk human papillomavirus and normal cytology

Risk of autism in offspring linked to maternal pregestational diabetes and severe obesity

2 Minute Medicine Rewind January 27, 2025

Teva: long acting olanzapine TEV’749 or Zyprexa shows success in schizophrenia

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Polypharmacy is associated with higher risk of mortality and hospitalizations among older adults
  • Oral nonstatin medication significantly lowers cholesterol in high-risk patients
  • Status epilepticus cause may predict likelihood of neurologic recovery but not short-term mortality
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.